News

The Manila Times16d
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
- ZEVASKYN is the only FDA-approved therapy to treat RDEB wounds with a single application - ...
The Malaysian Reserve17d
Bio-Techne’s Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in ...
WLNS.com16d
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment ...
CLEVELAND, July 15, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of the newest Qualified Treatment Center (QTC) for FDA-approved ZEVASKYN ...
How A 60-Year-Old Drug Developer Built A $4.4 Billion Biotech Treating ‘Butterfly Skin Disease’
Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the ...
Morningstar17d
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA ...
MINNEAPOLIS, July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN ...
Bio-Techne Corporation: Bio-Techne's Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene Therapy
Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western Technology played a key role in supporting ...